newsfilter
← Latest News
PR Newswire·

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines

The global cell therapy manufacturing market is on track to nearly double, from $7.17 billion in 2026 to over $14 billion by 2035[1]. The science has ...